Skip to main content

This website contains promotional content and is intended for Healthcare Professionals based in the United Kingdom only. Some content is only relevant to HCPs practising in Great Britain (England, Scotland, Wales).

Multiple Sclerosis

Multiple Sclerosis (MS) is a chronic, disabling disease affecting more than 2.3 million people worldwide

Curated Science

Get a 360 view of Multiple Sclerosis and the work we do with content selected for you

Prescribing Information can be found through the links in the Product Cards at the bottom of the page

Academy of Knowledge | MS Scientific Exchange Forum

Sanofi’s Heritage in MS

Science

Pre-recorded webinars by Dr Martin Duddy, Consultant Neurologist

AUBAGIO® (teriflunomide) – Real-World Considerations

Science

Neurology Products

AUBAGIO
teriflunomide

Prescribing Information GB
Prescribing Information NI

MAT-XU-2200676 (v4.0)
Date of preparation: April 2023

LEMTRADA
Alemtuzumab

Prescribing Information GB
Prescribing Information NI

MAT-XU-2200680 (v2.0)
Date of preparation: August 2022

MAT-XU-2200764 (v4.0)
Date of preparation: March 2023

YOU ARE NOW LEAVING THE SANOFI CAMPUS UK WEBSITE

You are going to a website that is not operated by Sanofi. Sanofi has no control over the content or availability of linked sites or resources, and accepts no liability or responsibility for them or for any loss or damage that may arise from your use of them. Please ensure that you read the legal and privacy policy sections of any third-party site to which you link.

Continue

Welcome to Sanofi Campus UK

This site is intended for UK healthcare professionals only and contains information on Sanofi UK’s medicines, educational resources and more. Please click the appropriate button below. By entering this site, you are confirming that you are a UK healthcare professional. This site contains promotional information. Please note that some of the content on the website is only relevant for HCPs practising in Great Britain (England, Scotland, Wales).

MAT-XU-2300297 (v2.0)
Date of Preparation: June 2023